University Hospital, Montpellier clinical trial pipeline

8 trials changed in the last 30 days: 1 stopped, 6 with notable changes, 1 with a minor change only.

1. Stopped

   ICAME · Medico-economic Evaluation of Therapeutic Adaptation…ICAME · Medico-economic Evaluation of Therapeutic Adaptation Guided by the Soluble Suppression of Tumorigenicity 2 (sST-2) Biomarker · Acute Heart Failure

   Trial terminated

   Also in this update: Final enrollment: 154 participants (planned 710); Study completion date changed from estimate of Jan 2027 to Apr 14, 2026

   University Hospital, Montpellier·Not applicable· NCT04554277· Registry history of NCT04554277 on ClinicalTrials.gov (opens the registry)

   Sep 24, 2026

2. Notable

   DEXPED · Intravenous Dexmedetomidine as an Adjuvant to…DEXPED · Intravenous Dexmedetomidine as an Adjuvant to Locoregional Anesthesia in Pediatric Surgery

   Primary completion pushed from Jul 3, 2027 to Jul 3, 2028

   University Hospital, Montpellier·Phase 2· NCT06736483· Registry history of NCT06736483 on ClinicalTrials.gov (opens the registry)

   Oct 13, 2026

3. Notable

   COPD-CARhE · Chronic Airway Disease, Mucus Rheology and…COPD-CARhE · Chronic Airway Disease, Mucus Rheology and Exacerbations

   Primary and study completion pushed from Feb 2026 to Feb 2027

   Also in this update: Trial status changed: Unknown → Recruiting

   University Hospital, Montpellier·Phase 4· NCT04339270· Registry history of NCT04339270 on ClinicalTrials.gov (opens the registry)

   Sep 24, 2026

4. Notable

   RECARDA · Impact of a Cardiac Rehabilitation Program on · Cardiac…RECARDA · Impact of a Cardiac Rehabilitation Program on · Cardiac Amyloidosis

   Primary and study completion pushed from Jan 30, 2029 to Sep 23, 2029

   Also in this update: Recruitment opened; Start date changed from estimate of Dec 30, 2026 to Sep 23, 2026

   University Hospital, Montpellier·Not applicable· NCT07494942· Registry history of NCT07494942 on ClinicalTrials.gov (opens the registry)

   Oct 8, 2026

5. Notable

   PROMESS_1 · National Cohort of Subjects at Risk of Developing…PROMESS_1 · National Cohort of Subjects at Risk of Developing Rheumatoid Arthritis

   Primary and study completion pushed from Dec 2027 to Dec 2029

   Also in this update: Recruitment opened; Interventions modified

   University Hospital, Montpellier·Not specified· NCT06876064· Registry history of NCT06876064 on ClinicalTrials.gov (opens the registry)

   Oct 1, 2026

6. Notable

   SCLEROCAR · Anti-CD19 CAR T-Cells in Systemic Sclerosis…SCLEROCAR · Anti-CD19 CAR T-Cells in Systemic Sclerosis Resistant to Immunosuppressive Therapy

   Enrollment reopened

   University Hospital, Montpellier·Phase 2· NCT07493395· Registry history of NCT07493395 on ClinicalTrials.gov (opens the registry)

   Oct 14, 2026

7. Notable

   TENVOL · Identification of Kinematic Variables Specific of…TENVOL · Identification of Kinematic Variables Specific of Patellar Tendinopathy in Athletes at Risk

   Recruitment opened

   University Hospital, Montpellier·Not applicable· NCT07406516· Registry history of NCT07406516 on ClinicalTrials.gov (opens the registry)

   Sep 21, 2026

• Stopped: an ongoing trial was terminated, suspended or withdrawn.
• Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
• Minor: routine progress and housekeeping, such as sites added or enrollment closed.